HVC
VYNE icon

Healthcare Value Capital’s VYNE Therapeutics VYNE Stock Holding History

Healthcare Value Capital’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$556K Sell
22,222
-2,778
-11% -$108K 1.1% 21
2021
Q2 		$1.58M Buy
25,000
+2,778
+13% +$220K 3.15% 14
2021
Q1 		$2.74M Sell
22,222
-5,556
-20% -$806K 6.1% 5
2020
Q4 		$3.16M Buy
27,778
+2,778
+11% +$349K 10.65% 3
2020
Q3 		$2.99M Buy
25,000
+1,389
+6% +$162K 9.85% 5
2020
Q2 		$2.94M Buy
23,611
+11,805
+100% +$1.6M 7.51% 4
2020
Q1 		$2.28M Buy
+11,806
New +$3.7M 3.83% 15

Other funds holding VYNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Healthcare Value Capital's VYNE Position: Q3 2021 in Review

Healthcare Value Capital reduced its VYNE Therapeutics (VYNE) stake by 11% in Q3 2021, selling an estimated $108K and leaving 22,222 shares worth $556K. The position accounts for 1.1% of the portfolio, ranked #21.

Healthcare Value Capital first reported a position in VYNE in Q1 2020 and has held it in 7 quarters since. The position peaked at $3.16M in Q4 2020. 64 funds tracked by Wall St. Rank hold VYNE as of Q3 2021.

  • Healthcare Value Capital held 22,222 shares of VYNE Therapeutics worth $556K as of Q3 2021.
  • Healthcare Value Capital sold 2,778 VYNE Therapeutics shares in Q3 2021, an estimated $108K.
  • VYNE Therapeutics made up 1.1% of Healthcare Value Capital's portfolio in Q3 2021, its #21 holding.
  • Healthcare Value Capital first reported a position in VYNE Therapeutics in Q1 2020 and has held it in 7 quarters since.
  • Healthcare Value Capital's VYNE Therapeutics position peaked at $3.16M in Q4 2020.
  • 64 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.